Aurinia to Present at the Bloom Burton & Co. Healthcare Investor Conference on May 3, 2018
Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH)(TSX:AUP) today announced that Celia Economides, Vice President, Corporate and Public
Affairs, will present at the Bloom Burton & Co. Healthcare Investor Conference on Thursday, May 3rd at 1:30pm EDT. A
webcast will be available and can be accessed via the investor section of the Aurinia website, www.auriniapharma.com. A replay will also be archived on the site following the event.
About Aurinia
Aurinia is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient
populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing
voclosporin, an investigational drug, for the treatment of LN, FSGS, and DES. The company is headquartered in Victoria, BC and
focuses its development efforts globally. For further information, see our website at www.auriniapharma.com.
About the Conference
The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are
interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate
updates from the premier Canadian publicly traded and private companies through presentations and private meetings.
About Bloom Burton & Co.
Bloom Burton & Co. (Bloom Burton Securities Inc.) is a firm dedicated to accelerating returns in the healthcare sector for both
investors and companies. Bloom Burton has an experienced team of medical, scientific, pharmaceutical, legal and capital markets
professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our
clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory,
equity research, business strategy and scientific consulting, advisory on direct investing and company creation and incubation
services. Bloom Burton Securities Inc. is a member of the Investment Industry Regulatory Organization of Canada (IIROC) and is also
a member of the Canadian Investor Protection Fund (CIPF).
We seek safe harbor.
Aurinia Pharmaceuticals Inc.
Investor Contact:
Celia Economides
VP, Corporate & Public Affairs
IR@auriniapharma.com
or
Media:
Christopher Hippolyte, 212-364-0458
Christopher.hippolyte@inventivhealth.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20180425006469/en/